Hepatitis C virus (HCV) RNA testing at the point of care is emerging as a practical way to identify and treat people living with HCV more quickly. As direct-acting antiviral drugs make cure routine, the real bottleneck has shifted to identifying who is infected and getting them started on treatment without losing them between appointments.